Combination therapies pushing up costs without benefits in mild asthmatics – Pharma Times


MD News (press release)

Combination therapies pushing up costs without benefits in mild asthmatics
Pharma Times
More costly combination therapies are significantly over-used in US patients with mild asthma, despite the lack of any apparent clinical benefit and despite
Mild Asthma – Most Medications Waste of Money, Report RevealsRillara News
New Study: Overuse of Combination Drug Therapy in Patients with Mild Asthma PR Newswire (press release)
ICS/LABA combination therapy increases asthma-related pharmacy costNews-Medical.net

all 19 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *